Teijin to distribute Exogen system in Japan:
This article was originally published in Clinica
Teijin is to begin distribution of Exogen's Sonic Accelerated Fracture Healing System (SAFHS) in Japan in June. The low intensity ultrasound device is approved in Japan for the healing of delayed and non-union bone fractures and Teijin has now received reimbursement approval from the Japanese Health and Welfare Ministry. The company, which has headquarters in Osaka and Tokyo, has paid a $400,000 milestone payment to Exogen. Piscataway, New Jersey-based Exogen's ultrasound and mechanical stress technologies are based on the principle that bone growth is stimulated by mechanical force.
You may also be interested in...
As sector awaits its aducanumab filing with bated breath, Biogen invests again in early stage neuroscience.
In case you missed it: catch up with snippets from interviews with industry leaders recently published by In Vivo.
While good clinical practice inspectors in the UK and the US collaborate on matters of common interest, they say that mutual recognition is simply not possible.